Liraglutide: 52 Weeks and 59 lb Later

Besides excessive weight gain, V.T. was not experiencing hypoglycemia or any other side effects from her therapy regimen. Because of the impact liraglutide had on V.T.'s appetite, other interventions were not necessary beyond discussing weight loss progress with a diabetes educator. * Using dia...

Full description

Saved in:
Bibliographic Details
Published in:Clinical diabetes Vol. 30; no. 3; pp. 123 - 125
Main Author: Peters, Kyle R
Format: Journal Article
Language:English
Published: Alexandria American Diabetes Association 22-06-2012
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Besides excessive weight gain, V.T. was not experiencing hypoglycemia or any other side effects from her therapy regimen. Because of the impact liraglutide had on V.T.'s appetite, other interventions were not necessary beyond discussing weight loss progress with a diabetes educator. * Using diabetes medications that may cause weight loss, instead of weight gain, can have a motivating effect that may result in a larger weight reduction than those observed in clinical trials. * Metformin and liraglutide in combination decreases the likelihood of hypoglycemia while allowing patients to maintain an AlCof<7%. * Patients should be educated about the risks and benefits of all medications available to treat diabetes.
ISSN:0891-8929
1945-4953
DOI:10.2337/diaclin.30.3.123